|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 5, 486-491, Copyright © 1991 by European Association for Cardio-thoracic Surgery
S Thelin, L Bagge, J Hultman, J Borowiec, L Nilsson and J Thorelius
Blood cell trauma and postoperative bleeding remain important problems in
cardiopulmonary bypass (CPB). We compared heparin-coated with non- coated
circuits in the pig. Twenty animals were perfused for 2 h at normothermia
using membrane oxygenators (Bentley Bos 50). Two groups were studied. In
the non-coated group (NC, n = 11) the CPB circuits used were without a
heparin coating. This group had systemic heparinization of 400 IU/kg to
maintain an ACT (activated clotting time) of over 400 s during CPB. In the
coated group (C, n = 9), all surfaces exposed to blood in the CPB circuits
were heparin-coated. This group had the heparin dose reduced to 25% (100
IU/kg) without further administration regardless of ACT. During CPB, group
C displayed shorter ACT (per definition), higher platelet count, platelet
adhesion and lower fibrinolysis and haemolysis (P less than 0.05) as
compared to group NC. No thromboembolic events were detected during CPB.
Three animals in group NC and 4 animals in group C were weaned from CPB and
protaminized. Four hours postoperatively, the leucocyte consumption was
two-fold greater and blood loss about four-fold greater in group NC as
compared with group C (P less than 0.05). Perfusion with heparin-coated
surfaces reduces blood cell trauma. The decreased postoperative blood loss
observed in group C is probably explained by the reduced dosages of heparin
and protamine.
ARTICLES
Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig
Department of Cardiovascular, University Hospital, Uppsala, Sweden.
This article has been cited by other articles:
![]() |
G. S. Murphy, E. A. Hessel II, and R. C. Groom Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P Wendel, A. M Scheule, F. S Eckstein, and G. Ziemer Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces Perfusion, January 1, 1999; 14(1): 21 - 28. [Abstract] [PDF] |
||||
![]() |
J. A. Hyde, J. A Chinn, and T. R Graham Platelets and cardiopulmonary bypass Perfusion, December 1, 1998; 13(6): 389 - 407. [PDF] |
||||
![]() |
S. Bannan, A. Danby, D. Cowan, S. Ashraf, and P. G. Martin Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy? Ann. Thorac. Surg., March 1, 1997; 63(3): 663 - 668. [Abstract] [Full Text] |
||||
![]() |
D. D. Muehrcke, P. M. McCarthy, K. Kottke-Marchant, H. Harasaki, J. Pierre-Yared, J. A. Borsh, D. A. Ogella, and D. M. Cosgrove BIOCOMPATIBILITY OF HEPARIN-COATED EXTRACORPOREAL BYPASS CIRCUITS: A RANDOMIZED, MASKED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 472 - 483. [Abstract] [Full Text] |
||||
![]() |
E. Ovrum, F. Brosstad, E. Am Holen, G. Tangen, and M. Abdelnoor Effects on Coagulation and Fibrinolysis With Reduced Versus Full Systemic Heparinization and Heparin-Coated Cardiopulmonary Bypass Circulation, November 1, 1995; 92(9): 2579 - 2584. [Abstract] [Full Text] |
||||
![]() |
E. Ovrum, E. A. Holen, G. Tangen, F. Brosstad, M. Abdelnoor, M.-A. L. Ringdal, R. Oystese, and R. Istad Completely Heparinized Cardiopulmonary Bypass and Reduced Systemic Heparin: Clinical and Hemostatic Effects Ann. Thorac. Surg., August 1, 1995; 60(2): 365 - 371. [Abstract] [Full Text] |
||||
![]() |
L. von Segesser, M. Pasic, M. Tonz, M. Lachat, B. Leskosek, and M. Turina Use of an intravascular gas exchanger: is low systemic heparinization safe? Perfusion, November 1, 1993; 8(6): 449 - 458. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |